Clinical trial
Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis…
NCT00161928 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00161928 |
|---|---|
| Title | Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants |
| Official title | A Randomized, Open-Label Trial of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Meningitis, Meningococcal |
| Intervention type | Biological |
| Interventions | Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT) |
| Enrollment | 330 |
| Start date | Apr 1, 2002 |
| Completion | Jan 1, 2003 |
| First posted | Sep 13, 2005 |
| Last update posted | May 21, 2015 |
| Countries | Austria, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: